Blog
RSS FeedPosted by Michael Wonder on 29 Sep 2016
More on NICE recommendation of Imlygic
28 September 2016 - More on NICE's guidance on the use of talimogene laherparepvec for unresectable metastatic melanoma. ...
Posted by Michael Wonder on 29 Sep 2016
NICE rejects LIlly's Portrazza
28 September 2016 - NICE is not in favour of the use of Portrazza on the NHS. ...
Posted by Michael Wonder on 28 Sep 2016
NICE recommends the reimbursement of Imlygic
28 September 2016 - NICE has recommended the relimbursement of Amgen's new cellular therapy for patients with malignant melanoma. ...
Posted by Michael Wonder on 28 Sep 2016
Patients with BRVO, a sight threatening eye condition, now have first-line access to EYLEA (aflibercept solution for injection) on the NHS
28 September 2016 - Bayer is pleased to announce that NICE has made the final recommendation for aflibercept for the treatment ...
Posted by Michael Wonder on 23 Sep 2016
NICE says yes to another hepatitis C drug
23 September 2016 - A new drug which effectively treats more genotypes of hepatitis C has been recommended for use in ...
Posted by Michael Wonder on 22 Sep 2016
NICE to recommend new drug to treat rare inherited bone disorder in children
22 September 2016 - NICE recommends ‘lifeline’ drug for babies and young children, in draft guidance. ...
Posted by Michael Wonder on 19 Sep 2016
NICE says no to expanding scope of Roche’s IPF drug
19 September 2016 - Patients in England and Wales with the lung scarring disease idiopathic pulmonary fibrosis will have to wait ...
Posted by Michael Wonder on 15 Sep 2016
NICE published draft guidance on new use for Gazyva
15 September 2016 - The Department of Health has asked the NICE to produce guidance on using obinutuzumab in combination with ...
Posted by Michael Wonder on 09 Sep 2016
More options to be made available to treat hepatitis C
9 September 2016 - Another ‘potential curative’ drug for people with chronic hepatitis C will be made available on the NHS. ...
Posted by Michael Wonder on 08 Sep 2016
Coil is more effective than pill as emergency contraception, says NICE
8 September 2016 - NICE is calling for women to be told that the coil is more effective than the ‘morning ...
Posted by Michael Wonder on 06 Sep 2016
NICE rejects Roche’s melanoma combination
6 September 2016 - Patients in England and Wales with melanoma will not be getting routine access to Roche's Cotellic/Zelboraf combination ...
Posted by Michael Wonder on 03 Sep 2016
NICE recommends Cancer Drugs Fund treatment for prostate cancer for routine NHS use
2 September 2016 - More prostate cancer patients will receive radium 223 after NICE approved it for routine NHS use. ...
Posted by Michael Wonder on 26 Aug 2016
NICE backs non-surgical option for fibroids
26 August 2016 - Women with uterine fibroids stand to gain routine access to a non-surgical treatment on the NHS for ...
Posted by Michael Wonder on 25 Aug 2016
NICE recommends Servier's Lonsurf (trifluridine with tipiracil hydrochloride)
24 August 2016 - New treatment for patients with advanced colorectal cancer. ...
Posted by Michael Wonder on 24 Aug 2016
NICE issues draft guidance on the use of Eylea (afilbercept)
24 August 2016 - NICE has issued draft final guidance on the use of Bayer's Eylea (aflibercept) on the NHS. ...